APA (7th ed.) Citation

Mian, S., Ugurel, S., & Schadendorf, D. (2016). Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients. Journal of clinical oncology, 23(22), . https://doi.org/10.1200/JCO.2005.03.164

Chicago Style (17th ed.) Citation

Mian, Shahid, Selma Ugurel, and Dirk Schadendorf. "Serum Proteomic Fingerprinting Discriminates Between Clinical Stages and Predicts Disease Progression in Melanoma Patients." Journal of Clinical Oncology 23, no. 22 (2016). https://doi.org/10.1200/JCO.2005.03.164.

MLA (9th ed.) Citation

Mian, Shahid, et al. "Serum Proteomic Fingerprinting Discriminates Between Clinical Stages and Predicts Disease Progression in Melanoma Patients." Journal of Clinical Oncology, vol. 23, no. 22, 2016, https://doi.org/10.1200/JCO.2005.03.164.